-transparent.png){kind=logo}
The carcinoembryonic antigen (CEA) blood test is included in most colorectal cancer follow up protocols, despite little clear evidence for its cost-effectiveness and survival benefit. In this study, patients' views were sought on the use of the CEA blood test in their follow up. Strong associations were found between the age of a patient's children and their concern about cancer recurrence and between concern about recurrence and anxiety about CEA test results (p<0.0001). Many patients expressed a desire for prognostic information, however uncertain or poor. Patients' views should be sought when designing colorectal cancer follow up protocols to ensure their needs are adequately addressed.
Nicola Steele, and
Rachel Haigh, and
Gillian Knowles, and
Melanie Mackean
December 1982,
Tumori,
Nicola Steele, and
Rachel Haigh, and
Gillian Knowles, and
Melanie Mackean
March 2016,
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland,
Nicola Steele, and
Rachel Haigh, and
Gillian Knowles, and
Melanie Mackean
December 1976,
Annals of surgery,
Nicola Steele, and
Rachel Haigh, and
Gillian Knowles, and
Melanie Mackean
November 1988,
Revista espanola de las enfermedades del aparato digestivo,
Nicola Steele, and
Rachel Haigh, and
Gillian Knowles, and
Melanie Mackean
June 1979,
The Japanese journal of surgery,
Nicola Steele, and
Rachel Haigh, and
Gillian Knowles, and
Melanie Mackean
March 2008,
Clinical colorectal cancer,
Nicola Steele, and
Rachel Haigh, and
Gillian Knowles, and
Melanie Mackean
August 1975,
Comprehensive therapy,
Nicola Steele, and
Rachel Haigh, and
Gillian Knowles, and
Melanie Mackean
January 2005,
Cancer investigation,
Nicola Steele, and
Rachel Haigh, and
Gillian Knowles, and
Melanie Mackean
February 1999,
International journal of colorectal disease,
Nicola Steele, and
Rachel Haigh, and
Gillian Knowles, and
Melanie Mackean
February 1998,
Medicina clinica,
